When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
AIM - AIM Immunotech nabs NCI grant to study Ampligen; shares up 8% premarket
AIM ImmunoTech Inc.
The National Cancer Institute (NCI) has issued an award of $14.54M to Roswell Park Comprehensive Cancer Center to test chemokine modulation incorporating AIM ImmunoTech (NYSEMKT:AIM)'s Ampligen as an immuno-modulator as part of a strategy to turn ‘cold' tumors into ‘hot' tumors.
More news on: AIM ImmunoTech Inc., Healthcare stocks news, Stocks on the move,